bioMérieux S.A.
bioMérieux S.A. BIM.PA Peers
See (BIM.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIM.PA | €119.10 | +0.59% | 14B | 32.72 | €3.64 | +0.76% |
| ERF.PA | €63.36 | +2.89% | 11.1B | 30.32 | €2.09 | +0.97% |
| LBIRD.PA | €18.60 | -1.06% | 409.4M | 71.54 | €0.26 | N/A |
| ALECR.PA | €17,800.00 | N/A | 89.8M | 12.55 | €1,418.84 | N/A |
| MDXH.BR | €3.02 | -3.76% | 85.6M | -1.58 | -€1.91 | N/A |
| BCART.BR | €0.29 | N/A | 27.2M | -0.32 | -€0.92 | N/A |
| ALBIO.PA | €1.22 | -1.61% | 22.2M | -0.37 | -€3.29 | N/A |
| ALPRE.PA | €3.58 | +3.77% | 13.4M | -3.01 | -€1.19 | N/A |
| EEP.MC | €0.54 | N/A | 6.3M | -54.00 | -€0.01 | N/A |
| MLAHC.PA | €0.60 | N/A | 5.4M | -10.00 | -€0.06 | N/A |
Stock Comparison
BIM.PA vs ERF.PA Comparison
BIM.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIM.PA stands at 14B. In comparison, ERF.PA has a market cap of 11.1B. Regarding current trading prices, BIM.PA is priced at €119.10, while ERF.PA trades at €63.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIM.PA currently has a P/E ratio of 32.72, whereas ERF.PA's P/E ratio is 30.32. In terms of profitability, BIM.PA's ROE is +0.11%, compared to ERF.PA's ROE of +0.05%. Regarding short-term risk, BIM.PA is less volatile compared to ERF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for BIM.PA.